Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.9 USD | +1.06% | -10.80% | -4.04% |
Mar. 08 | Truist Securities Adjusts Price Target on Compugen to $5 From $4, Maintains Buy Rating | MT |
Mar. 05 | Transcript : Compugen Ltd., Q4 2023 Earnings Call, Mar 05, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.04% | 168M | |
-1.42% | 41.35B | |
+42.15% | 40.38B | |
+1.97% | 39.05B | |
-14.19% | 26.67B | |
+1.82% | 24.07B | |
-24.55% | 18.36B | |
-4.07% | 11.68B | |
+21.36% | 11.6B | |
+8.20% | 11.15B |
- Stock Market
- Equities
- CGEN Stock
- News Compugen Ltd.
- Compugen : Expects $6 Million Milestone Payment From AstraZeneca for First Patient Dosed in Antibody-Derived Drug Study